In addition, CD4+ T cells from donors carrying rs228614-G, an MS risk variant proximal to NF-κB1, exhibited increased IκBα degradation and NF-κB p65 nuclear translocation after TNF-α stimulation (34). The gene discussed is CD4; the disease is myeloid sarcoma.